PROF250117P12500
- 0.00
- 0.000.00%
Profound Medical Newsroom
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $17
Profound Medical (PRN) Receives a Buy From Lake Street
Raymond James Initiates Profound Medical(PROF.US) With Buy Rating, Announces Target Price $17
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $17
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Raises Target Price to $17
Stifel Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $12
Stifel Nicolaus Reaffirms Their Buy Rating on Profound Medical (PRN)
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $16.5
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $16.5
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $16.5
Lake Street Keeps Their Buy Rating on Profound Medical (PRN)
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $16.5
Profound Medical (PRN) Receives a Buy From Stifel Nicolaus
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Raises Target Price to $16.5
Profound Medical (PRN) Receives a Buy From Lake Street
Profound Medical Upgraded at Stifel on Medicare Policy Update
Profound Medical Analyst Ratings
Buy Rating Affirmed for Profound Medical on Reimbursement and Market Expansion Prospects
Alliance Global Partners Trims Price Target on Profound Medical to $10.80 From $12.75, Maintains Buy Rating
Profound Medical Analyst Ratings